Article

Sponsored Content

MALDI-8020

Author(s):

 

 

 

 

 

MALDI-8020: Small size. Massive impact

 

 

 

 

 

 

The MALDI-8020 is the latest in a long line of MALDI-TOF products from Shimadzu. This benchtop, linear MALDI-TOF mass spectrometer delivers outstanding performance in a compact footprint, making it an ideal choice for today’s increasingly demanding laboratories.

 

Key features:
   •    Linear mode (positive ion) MALDI-TOF
   •    200 Hz solid‒state laser, 355 nm
   •    Load-lock chamber for fast sample introduction
   •    UV laser‒based source cleaning (patented)
   •    Small size due to benchtop design with a compact footprint
   •    Quiet operation (<55 dB)

 

Linear mode instruments have traditionally been the instruments of choice in MALDI-TOF-based quality control (QC) and profiling workflows, and the MALDI-8020 is no exception. Peptides, proteins, polymers or oligonucleotides ‒ the instrument is capable of delivering the performance required for QC applications. Research laboratories will also benefit from the MS capabilities of the instrument through the rapid mass-measurement of samples.

 

Contact Details:

Albert-Hahn-Str. 6-10, 47269 Duisburg, Germany
Phone: +49-203-76 87 0
Fax: +49-203-76 66 25
shimadzu@shimadzu.euwww.shimadzu.eu

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content